Key result
CABG linked to ~45% lower 5-year MACE risk vs. PCI in matched men.
Why the study?
Women have higher mortality than men after CABG, and the influence of sex on PCI outcomes is controversial, with limited real-world comparative data.
Cohort (n=3,153)
Yes
Hazard Ratio: 0.548 (95% CI 0.424–0.682)
Absolute Event Rate: 79.5% vs 69.5%
p-value: p=<0.001
Sex may modify revascularization outcomes; leaves open whether CABG benefits women equivalently to men in randomized settings.
Objectives: Women have a higher mortality than men following coronary artery bypass grafting (CABG). The influence of patient sex on outcomes of percutaneous coronary interventions (PCI) is controversial. Since patient selection for randomized clinical trials may not reflect clinical practice, we investigated the impact of sex on outcomes of CABG versus PCI in a comprehensive registry of coronary revascularization (CR). Methods: All patients undergoing CR in a network of eight community hospitals were enrolled. Follow-up was obtained after 5 years (median, 79.7 months). ST-elevation myocardial infarction (MI) patients were excluded. Propensity-score matching accounted for differences between groups. Results: There were 2162 men (673 CABG, 1489 PCI) and 991 women (294 CABG, 697 PCI). Survival free from major adverse cardiac events (MACE)-all cause mortality, nonfatal MI, re-intervention at 5 years for PCI versus CABG was 77.1 +/- 1.1 vs. 83.1 +/- 1.5, hazard ratio (HR) 0.588 (95% confidence interval [CI]: 0.491-0.704; P < 0.001) for men, but 75.0 +/- 1.6 vs. 74.5 ± 2.5, HR 0.869 (95% CI: 0.687-1.100; P = 0.24) for women. After matching, MACE-free survival for men remained significantly different, 69.5 +/- 2.2 vs. 79.5 +/- 2.0, HR 0.548 (95% CI: 0.424-0.682; P < 0.001) but not for women, 68.1 +/- 3.4 vs. 69.4 +/- 3.4, HR 0.752 (95% CI: 0.540-1.049; P = 0.093). Conclusions: In a 'real world' unselected cohort of CR patients, men enjoy improved survival and reduced MACE with CABG versus PCI. Outcomes for women are worse than for men and are equivalent with either procedure, emphasizing importance of accounting for sex in assessing outcomes of comparative CR procedures.
No takes yet. Share an insight, caveat, or question.
Kurlansky et al. (2016) conducted a cohort in Coronary Artery Disease (n=3,153). CABG vs. PCI was evaluated on Survival free from major adverse cardiac events (MACE) at 5 years in matched men (HR 0.548, 95% CI 0.424-0.682, p=<0.001). CABG significantly improved 5-year MACE-free survival compared to PCI in matched men (HR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: